Novonix Limited
NVNXF
$0.3112
-$0.0088-2.75%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.93M | 5.89M | 5.85M | 6.36M | 6.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.93M | 5.89M | 5.85M | 6.36M | 6.88M |
| Cost of Revenue | 1.41M | 1.59M | 1.77M | 1.41M | 1.06M |
| Gross Profit | 4.52M | 4.30M | 4.08M | 4.95M | 5.82M |
| SG&A Expenses | 46.01M | 47.54M | 49.08M | 47.86M | 46.65M |
| Depreciation & Amortization | 4.60M | 4.58M | 4.57M | 4.62M | 4.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.87M | 58.57M | 60.27M | 59.08M | 57.89M |
| Operating Income | -50.93M | -52.67M | -54.41M | -52.71M | -51.01M |
| Income Before Tax | -66.15M | -70.44M | -74.72M | -60.89M | -47.06M |
| Income Tax Expenses | 97.60K | 97.60K | 97.60K | -51.20K | -200.00K |
| Earnings from Continuing Operations | -66.25 | -70.53 | -74.82 | -60.84 | -46.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -66.25M | -70.53M | -74.82M | -60.84M | -46.86M |
| EBIT | -50.93M | -52.67M | -54.41M | -52.71M | -51.01M |
| EBITDA | -46.95M | -48.71M | -50.46M | -48.61M | -46.76M |
| EPS Basic | -0.12 | -0.14 | -0.15 | -0.12 | -0.10 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.07 | -0.07 | -0.06 |
| EPS Diluted | -0.12 | -0.14 | -0.15 | -0.12 | -0.10 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.07 | -0.07 | -0.06 |
| Average Basic Shares Outstanding | 2.27B | 2.13B | 1.99B | 1.97B | 1.95B |
| Average Diluted Shares Outstanding | 2.27B | 2.13B | 1.99B | 1.97B | 1.95B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |